Mr. Sakamoto holds a Ph.D. in Medicine. After working in the Development Division of Fujisawa Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.), he began work at Linical in July 2005. Following experiences as a project leader on various clinical trials, including trials of drugs for intractable diseases, and as Manager of Clinical Development, in 2010 he began expanding Linical’s oncology business, as the Director of the Oncology Business Unit. In 2014, he secured the contract for Linical’s first Asian clinical trial, and as the Director of the Asian Development Unit, he worked on developing a platform for the company’s current systems for Asian and global trials. Since 2015 he has served as President of Linical USA Inc., devoted to expanding full-scale development of Linical’s business in the USA, the world’s biggest market.